Related Experiment Video
Updated: Jun 5, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Valproate decreases frequency facilitation at mossy fiber--CA3 synapses after status epilepticus
Pishan Chang1, Matthew C Walker
1UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.
Abstract:
Mossy fiber to CA3 synapses exhibit metaplasticity during the development of epilepsy, and valproate in control animals can modulate long-term plasticity at this synapse. Here we show that valproate alters frequency facilitation (short-term plasticity) at this synapse in hippocampal slices from post-status epilepticus but not control animals. This indicates that valproate can have specific actions in the "epileptic" brain.
Insights
Valproate specifically impacts short-term synaptic plasticity in the epileptic brain, not in healthy controls. This suggests targeted therapeutic actions of valproate in epilepsy.
Area of Science:
- Neuroscience
- Epilepsy Research
- Synaptic Plasticity
Background:
- Mossy fiber to CA3 synapses are crucial for memory and exhibit metaplasticity during epilepsy development.
- Valproate is known to modulate long-term plasticity in healthy brain tissue.
Purpose of the Study:
- To investigate the specific effects of valproate on synaptic plasticity in the context of epilepsy.
- To determine if valproate's actions differ between healthy and epileptic brain tissue.
Main Methods:
- Electrophysiological recordings were performed on hippocampal slices.
- Frequency facilitation (a form of short-term plasticity) was measured at mossy fiber to CA3 synapses.
- Experiments were conducted on slices from both control animals and animals post-status epilepticus.
Main Results:
- Valproate significantly altered frequency facilitation at mossy fiber to CA3 synapses in slices from post-status epilepticus animals.
- Valproate did not alter frequency facilitation in slices from control animals.
- These findings highlight a differential effect of valproate based on the brain's epileptic state.
Conclusions:
- Valproate exhibits specific actions on short-term synaptic plasticity within the epileptic brain.
- This suggests that valproate may have targeted therapeutic mechanisms in epilepsy that differ from its effects in healthy brains.
More Related Videos
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

